• How are we ensuring under-served patient populations voices are considered in trial format?

• Optimizing both population data and clinical data analytics to develop accessible and equitable clinical trials.

• Improving global data collection and analytics to provide direction of health equity strategies.

• Discussing pharmaceutical solutions for health equity through clinical trial diversity in the United States.

• Reviewing the global health equity landscape through the lens of regulation and collaboration efforts.

• Solutions to maximise the implementation of clinical trial & health equity education tools across the clinical trial landscape.

• Deciphering the most effective communication methods for diverse populations.

• Demonstrating how health literacy innovation leads to quality patient experience and improved patient engagement & recruitment.